Covidien (NYSE:COV) said it’s searching for a new CFO after Charles Dockendorff announced his plans to retire from the company at the end of 2014.
Dockendorff has been with the company since 1989, serving in a variety of finance-related roles. He was named CFO of Covidien predecessor Tyco Healthcare in 1995, helping lead the company to $10 billion in sales in 2007.
“Chuck’s extraordinary leadership over the last 25 years has contributed directly to our global growth and the value we have created for shareholders. We anticipate a seamless transition and are pleased to have the benefit of his experience and counsel during the transition period,” chairman, CEO & president José Almeida said in prepared remarks.
Dockendorff will assist in the search for his successor and serve as an advisor, since the company does not have a immediate option at this time.
Orthofix names interim chairwoman
Orthofix (NSDQ:OFIX) named Kathleen Regan as its interim chairwoman, following the departure of Randy Thurman. Regan is a venture partner for Radius Venture.
Read more
California Healthcare Institute CEO leaves for Gilead Sciences
California Healthcare Institute CEO David Gollaher is leaving to join Gilead Sciences as its new head of policy and public health. CHI public policy VP Todd Gillenwater is stepping in on an interim basis.
Read more
Cardica names new sales VP
Cardica (NSDQ:CRDC) named Liam Burns as its VP of sales and marketing. Burns has more than 20 years of medical device sales and marketing expertise with the likes of Johnson & Johnson (NYSE:JNJ).
Read more
Cooper Companies appoints general counsel
Cooper Cos. (NYSE:COO) named Randal Golden as its general counsel, starting in February. Golden has worked with Cooper since 2010 and has 26 years of corporate legal service under his belt through work with Align Technology (NSDQ:ALGN).
Read more
